Search - tctmd.com

Displaying 121 - 140 of 307

Sort: Relevancy | Date

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

News Conference News TCT 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

Todd Neale

September 22, 2018

Presentation TCT 2018

DANCE: Two-Year Outcomes of Adventitial Dexamethasone Delivery During Femoropopliteal Revascularization

Presenter: Lindsay S. Machan, Craig M. Walker, Ehrin J. Armstrong

September 22, 2018

Presentation TCT 2018

IN.PACT DCB: Pooled Multistudy Assessment of Drug-Coated Balloon Treatment for Femoropopliteal Peripheral Artery Disease

Presenter: Lindsay S. Machan, Craig M. Walker, Mehdi H. Shishehbor

September 22, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

Presentation TCT 2018

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Presenter: William A. Gray

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

Presentation

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

May 08, 2018

News Daily News

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

L.A. McKeown

May 08, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Conference News ISET 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Caitlin E. Cox

February 08, 2018

Presentation TCT 2017

TCT 60: Stent Versus Non-Stent Strategies for Endovascular Treatment of Femoropopliteal Peripheral Artery Disease: Insights from the XLPAD Registry

Presenter: Sahil A. Parikh, Micah Steinbrecher, MD

October 31, 2017

Presentation TCT 2017

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

Presenter: David P. Faxon, Joseph A. Hill, Yusuke Miyashita

October 31, 2017

Presentation TCT 2017

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

Presenter: Tony Das, Thomas Zeller, Grzegorz Halena, MD

October 30, 2017

Presentation TCT 2017

The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study

Presenter: Tony Das, Thomas Zeller, Georgios Bouras

October 30, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 26, 2017

Advertisement

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

DANCE: Two-Year Outcomes of Adventitial Dexamethasone Delivery During Femoropopliteal Revascularization

IN.PACT DCB: Pooled Multistudy Assessment of Drug-Coated Balloon Treatment for Femoropopliteal Peripheral Artery Disease

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

TCT 60: Stent Versus Non-Stent Strategies for Endovascular Treatment of Femoropopliteal Peripheral Artery Disease: Insights from the XLPAD Registry

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content